증권 기록 · 과거 분기 (아카이브)
TARS
Tarsus Pharmaceuticals, Inc. · Healthcare · Biotechnology
16추적 보유자
0Δ 보유자
11.66M보유 주식 수
$693.15M보고 가치
+1신규 편입 포지션
−2청산
모멘텀 입력값 (비교 가능한 운용사): 보유자 폭 0.0% · 주식 흐름 -7.2% · 순 신규 포지션 -6.2% — 산식
모든 소유권 수치: 추적 대상 13F 운용사 한정, 보통주 포지션, 보고 기간 Q3 2025
시계열 보유 현황
| 분기 | 보유자 | Δ | 주식 수 | 보고 가치 | 신규 | 청산 |
|---|---|---|---|---|---|---|
| Q2 2026 | 102 | +3 | 26.51M | $1.67B | +7 | −3 |
| Q1 2026 | 101 | +5 | 27.05M | $1.90B | +10 | −6 |
| Q4 2025 | 97 | 0 | 27.39M | $2.24B | +2 | −1 |
| Q3 2025 | 16 | 0 | 11.66M | $693.15M | +1 | −2 |
| Q2 2025 | 14 | 0 | 10.63M | $430.62M | — | — |
| Q1 2025 | 11 | +2 | 4.92M | $252.88M | +2 | — |
| Q4 2024 | 9 | 0 | 3.55M | $196.55M | — | — |
| Q3 2024 | 8 | 0 | 2.33M | $76.49M | — | — |
| Q2 2024 | 8 | — | 2.46M | $66.86M | — | — |
보유 현황 · Q3 2025
| # | 운용사 | 주식 수 | Δ 주식 수 | 가치 | 비중 | 보유 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (패시브) | 3.78M | -0.3% | $224.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (패시브) | 2.27M | -1.1% | $135.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (패시브) | 2.27M | -1.1% | $135.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (패시브) | 2.27M | -1.1% | $135.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (패시브) | 2.27M | -1.1% | $135.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | The Vanguard Group ✦ (패시브) | 2.27M | -1.1% | $135.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 1.91M | — | $113.65M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Geode Capital Management ✦ (패시브) | 944.50K | +1.1% | $56.14M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Geode Capital Management ✦ (패시브) | 944.50K | +1.1% | $56.14M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | State Street Global Advisors ✦ (패시브) | 936.16K | -4.6% | $55.64M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 34 | D. E. Shaw & Co. ✦ | 598.31K | -17.3% | $35.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | D. E. Shaw & Co. ✦ | 598.31K | -17.3% | $35.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | T. Rowe Price ✦ | 452.86K | +18.0% | $26.91M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 452.86K | +18.0% | $26.91M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 38 | Goldman Sachs Group ✦ | 341.01K | — | $20.27M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Goldman Sachs Group ✦ | 341.01K | — | $20.27M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | JPMorgan Chase ✦ | 154.38K | — | $9.17M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Millennium Management ✦ | 100.57K | +73.0% | $5.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 57 | Citadel Advisors ✦ | 43.28K | -81.1% | $2.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 58 | Renaissance Technologies ✦ | 41.60K | 신규 | $2.47M | 0.0% | New | 1 | SEC ↗ |
| 59 | AQR Capital Management ✦ | 37.09K | -30.8% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 60 | AQR Capital Management ✦ | 37.09K | -30.8% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 61 | AQR Capital Management ✦ | 37.09K | -30.8% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 62 | AQR Capital Management ✦ | 37.09K | -30.8% | $2.20M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 63 | Fidelity (FMR) ✦ | 21.86K | +10.1% | $1.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 64 | Fidelity (FMR) ✦ | 21.86K | +10.1% | $1.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 65 | Wellington Management ✦ | 17.35K | -86.0% | $1.03M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 66 | Wellington Management ✦ | 17.35K | -86.0% | $1.03M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 67 | Wellington Management ✦ | 17.35K | -86.0% | $1.03M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 68 | Wellington Management ✦ | 17.35K | -86.0% | $1.03M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 69 | Two Sigma Investments ✦ | 9.98K | -47.5% | $592,993 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"해당 운용사 비중" = 해당 운용사의 신고된 13F 주식 가치 대비 포지션 비중 — 확신도 지표. ✦ = 선별 운용사.
신규 매수자
| Renaissance Technologies | $2.47M | 0.0% |
청산됨
| Adage Capital Partners | $22.00M | 이었음 0.0% |
| Norges Bank | $19.09M | 이었음 0.0% |
전체 시장 맥락: 전체 13F 공시 기관 기준 (SEC 구조화 데이터, Q1 2026): 252 보유 기관, 45.11M 주식, $3.08B 신고 기준. 이는 위의 추적 유니버스 수치와 다른 이전 기간으로, 두 수치는 절대 혼용되지 않습니다.
공동 보유 빈도 높음
이 증권의 추적 보유자들이 가장 많이 함께 보유하는 종목 — 기본적 관계가 아닌 공동 보유 건수 기준.
출처: 파싱된 13F 보통주 포지션 기반 보유 현황(추적 유니버스, 변동 비교 세트); 내부자 행은 Form 3/4/5에서; 지분은 Schedule 13D/13G에서 수집; 모든 공시는 SEC EDGAR 원문으로 연결됩니다.
보고 기간: Q3 2025 ·
방법론 ·
API를 통해 조회